GBAF Logo
Global Banking & Finance Awards® 2026 Nominations open, free to enter Nominate now →
T

Tianshui Zhongxing Bio-technology Co 002772.SZ · CNY

Consumer Staples · Shenzhen · 🇨🇳 China

Compare

7.82

-1.01%

Close of 9 Nov 2026, in CNY

Search any instrument

Reference data, closing prices and charts across 45,000 companies, plus crypto, commodities and currencies.

About Tianshui Zhongxing Bio-technology Co

Its shares trade on Shenzhen under the ticker 002772.SZ. It has been listed since 26 June 2015. In the fiscal year to 31 December 2025, it reported revenue of CN¥2.10bn and net income of CN¥335.0m. At that date it held total assets of CN¥7.09bn and shareholders' equity of CN¥3.53bn.

Tianshui Zhongxing Bio-Technology Co., Ltd. engages in the research, development, and manufacturing of edible and medical mushrooms. The company is headquartered in Tianshui, Gansu. The company went IPO on 2015-06-26. The firm's edible mushroom products include enoki mushroom, king oyster mushroom and beech mushroom. Through its subsidiaries, the Company also involves in the production and sale of edible mushroom, medicinal mushroom and auxiliary materials, research and development, application and promotion of microbial technology, biological engineering technology and new agricultural technologies, as well as the manufacture, process and distribution of agricultural by-products.

Figures and description from our data supplier, not checked against the company's own report.

Company facts

Sector
Consumer Staples
Industry
Food Products
Listed since
26 Jun 2015
Employees
5,595
Website
tszxjy.cn ↗

Leadership

Pay as last reported

  • Mr. Boshu GaoChairman of the Board, since 2012CN¥360,000
  • Mr. Chunhui TaoVice Chairman of the Board, Deputy General Manager, since 2020CN¥300,000
  • Mr. Min LiChief Financial OfficerCN¥324,000
  • Mr. Liang LiuGeneral Manager, Director, since 2012CN¥372,000
  • Mr. Shoufu ZhangDeputy General Manager
  • Mr. Jinjun ZhouDeputy General ManagerCN¥300,000
  • Ms. Xiaoli QianSecretary of the BoardCN¥204,300
  • Mr. Xiaojun ShaoDirector
  • Mr. Guoqing WangDirectorCN¥76,200
  • Mr. Boyu YaoDirectorCN¥52,800
  • Ms. Lin DangIndependent Director
  • Ms. Ping JiaIndependent Director

Environmental, social and governance

Scores out of 100, from our data supplier

ESG
Overall
0
Environment
0
Social
0
Governance
0

SWOT analysis

AI-generated by our data supplier. Not written or checked by our editors.

AI-generated

Strengths

  • Edible mushroom products include enoki, king oyster, and beech mushrooms.
  • The company employs 5,595 full-time employees in Tianshui, Gansu.
  • Subsidiaries produce medicinal mushrooms and microbial technology applications.

Weaknesses

  • Tianshui, Gansu is a less prominent market for mushroom products.
  • The company's IPO was in 2015, limiting recent growth opportunities.
  • Edible mushroom products face competition from traditional food sources.

Opportunities

  • Expanding into medical mushroom markets in China's healthcare sector.
  • Growing demand for microbial technology in agricultural applications.
  • Increasing global interest in edible mushroom products.

Threats

  • Regulatory changes in China's food safety laws could impact production.
  • Economic downturns in Gansu province may reduce consumer spending.
  • Climate change affecting mushroom cultivation in Tianshui region.

Sources and methodology

Data on this tab
Our data supplier
Chart on the Overview
TradingView

Nothing here is investment advice. Prices can be delayed or wrong, so check with the exchange before relying on them. Data for this page. How we cover markets.